Hangzhou DAC Biotech Co., Ltd is based in Hangzhou, Zhejiang, China. It has raised $156M in total funding. Latest round: Series C.
Hangzhou DAC Biotech Co., Ltd funding overview
Hangzhou DAC Biotech Co., Ltd is based in Hangzhou, Zhejiang, China. Hangzhou DAC Biotech Co., Ltd has raised $156M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2022. The round record for Hangzhou DAC Biotech Co., Ltd runs through 2022; nothing later has been disclosed. Investors on record include Johnson & Johnson Development Corporation.
Hangzhou DAC Biotech Co., Ltd at a glance
Total raised
$156M
Latest round
Series C
Latest round date
January 2022
Headquarters
Hangzhou, Zhejiang, China
Notable investors
Johnson & Johnson Development Corporation
Frequently asked about Hangzhou DAC Biotech Co., Ltd funding
How much has Hangzhou DAC Biotech Co., Ltd raised?
Hangzhou DAC Biotech Co., Ltd has raised $156M in total disclosed funding across the rounds on record.
Who has invested in Hangzhou DAC Biotech Co., Ltd?
Johnson & Johnson Development Corporation are named among the investors backing Hangzhou DAC Biotech Co., Ltd.
What was the latest Hangzhou DAC Biotech Co., Ltd funding round?
The most recent disclosed round is a Series C, announced in January 2022.
Where is Hangzhou DAC Biotech Co., Ltd based?
Hangzhou DAC Biotech Co., Ltd is based in Hangzhou, Zhejiang, China.
When did Hangzhou DAC Biotech Co., Ltd last raise?
The last disclosed Hangzhou DAC Biotech Co., Ltd round closed in January 2022 at Series C.
Totals shown for Hangzhou DAC Biotech Co., Ltd aggregate every disclosed round on file. To see how that compares, browse the companies in Hangzhou and the investors behind them below.
Companies related to Hangzhou DAC Biotech Co., Ltd (22)
